Last week, the European Commission (the “Commission”) retracted its preliminary position on treating hemp-derived cannabidiol (“CBD”) and other extracts derived from the flowering tops of the Cannabis sativa L. plant as narcotics under the U.N. Single Convention on Narcotic Drugs of 1961 (the “Single Convention”). We were relieved to see this development; faithful readers of
On Thursday, January 28, we will be hosting a FREE hour-long webinar discussing the business side of medical and recreational cannabis in Mexico. REGISTER TODAY! As we have reported in this blog, new legislation to regulate cannabis is in the works here in Mexico. A draft “Law for the Regulation of Cannabis” (the “Cannabis Law”) is under discussion by
Canna Law Blog escribiendo sobre la norma definitiva provisional (IFR) de la Agencia Antidrogas (DEA) relativa al cáñamo desde su publicación en agosto en el Registro Federal: ¡Cuidado! La DEA acaba de aprobar una norma provisional PERJUDICIAL que afecta al CBD del cáñamo y a otros cannabinoides. La DEA no quiere que te preocupes por su nuevo cáñamo
On August 21, the Drug Enforcement Agency (the “DEA”) released an Interim Final Rule (the “Rule”), which, in part, suggests that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 percent on a dry weight basis. “Any point” includes even fleetingly during
Keeping up with the multitude of (shifting) state and municipal cannabis regulations is a daunting task for any multi-state cannabis operator. One well-known tool for doing so has been CannaRegs, which offers a web-based subscription service to aggregate and organize cannabis rules, regulations, and legislation. In January 2020, CannaRegs was acquired by Fyllo, “a digital
Last week, Oregon Representative Kurt Schrader (D) and Virginia Representative Morgan Griffith (R) introduced The Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2020 (“H.R. 8179”). If enacted in its current form, H.R. 8179 would legalize the manufacture, sale and marketing of hemp, hemp-derived cannabidiol and other hemp extracts (collectively referred to
Until a few weeks ago, everyone in the hemp world thought the next big development would come from the federal Food and Drug Administration (after all, the FDA recently submitted proposed guidance to the White House, which has yet to be released). Unfortunately, the Drug Enforcement Administration (DEA) dropped a surprise interim hemp rule a
Perhaps the most exciting announcement in the world of celebrity cannabis companies came last week with the announcement of Martha Stewart’s new line of hemp-derived CBD products, which include tinctures, soft gels, and “pâte des fruit.” The products are manufactured and sold through Canadian company Canopy Growth Corporation, which also produces Snoop Dogg’s cannabis brand
Everyone in the hemp industry knows that last fall the U.S. Department of Agriculture (“USDA”) released its interim hemp rules governing the production of hemp. Our hemp-CBD attorneys have written extensively about the new hemp rules and their shortcomings, as well as the panoply of different hemp regulations at the state level and the DEA’s
Every week, clients ask us to review their hemp-derived cannabidiol (“Hemp CBD”) products to ensure “full compliance.” Unfortunately, given the patchwork of often conflicting state labeling laws, and the lack of a federal pathway for the sale and marketing of these products, it is virtually impossible for Hemp CBD stakeholders to meet compliance standards. Consequently,
